Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to $150000.0.

  • Biodesix's Non-cash Items fell 9127.4% to $150000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $150000.0, marking a year-over-year decrease of 9127.4%. This contributed to the annual value of $1.9 million for FY2024, which is 9336.1% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's Non-cash Items is $150000.0, which was down 9127.4% from $2.8 million recorded in Q2 2025.
  • Biodesix's 5-year Non-cash Items high stood at $37.7 million for Q1 2021, and its period low was $31000.0 during Q1 2025.
  • Its 5-year average for Non-cash Items is $3.9 million, with a median of $1.3 million in 2021.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 642993.37% in 2021, then tumbled by 9682.11% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Non-cash Items stood at $6.3 million in 2021, then plummeted by 76.32% to $1.5 million in 2022, then tumbled by 35.26% to $964000.0 in 2023, then skyrocketed by 93.36% to $1.9 million in 2024, then crashed by 91.95% to $150000.0 in 2025.
  • Its Non-cash Items was $150000.0 in Q3 2025, compared to $2.8 million in Q2 2025 and $31000.0 in Q1 2025.